XKRX:217330 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
3,200
-10 (-0.31%)
Apr 11
What is a stock summary page? Click here for an overview.
Business Description
Cytogen Inc
ISIN : KR7217330000
Share Class Description:
XKRX:217330: Ordinary SharesCompare
Compare
Traded in other countries / regions
217330.Korea Index Membership
KOSDAQ Composite Index IPO Date
2018-11-22Description
Cytogen Inc is a Korea based company engaged in developing HD Microporous chip using microfluidics and nanotechnology and it captures viable CTCS (circulating tumor cells) from cancer patients blood. The firm operates in two business areas including Liquid Biopsy Applications and Liquid Biopsy Platforms.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.78 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.31 | |||||
| Debt-to-EBITDA | -1.08 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 0.3 | |||||
| Beneish M-Score | 0.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 313.2 | |||||
| 3-Year EBITDA Growth Rate | -47.9 | |||||
| 3-Year EPS without NRI Growth Rate | -22 | |||||
| 3-Year FCF Growth Rate | -49.1 | |||||
| 3-Year Book Growth Rate | 17 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.17 | |||||
| 9-Day RSI | 29.74 | |||||
| 14-Day RSI | 29.74 | |||||
| 3-1 Month Momentum % | -7.93 | |||||
| 6-1 Month Momentum % | -40.18 | |||||
| 12-1 Month Momentum % | -66.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | |||||
| Quick Ratio | 9.83 | |||||
| Cash Ratio | 8.75 | |||||
| Days Inventory | 28.13 | |||||
| Days Sales Outstanding | 56.4 | |||||
| Days Payable | 39.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.6 | |||||
| Shareholder Yield % | -2.97 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.93 | |||||
| Operating Margin % | -97.75 | |||||
| Net Margin % | -156.88 | |||||
| FCF Margin % | -97.64 | |||||
| ROE % | -31.49 | |||||
| ROA % | -22.26 | |||||
| ROIC % | -36.75 | |||||
| 3-Year ROIIC % | 3.29 | |||||
| ROC (Joel Greenblatt) % | -231.86 | |||||
| ROCE % | -22.12 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 6.68 | |||||
| PB Ratio | 1.52 | |||||
| Price-to-Tangible-Book | 2.1 | |||||
| EV-to-EBIT | -3.02 | |||||
| EV-to-EBITDA | -3.47 | |||||
| EV-to-Revenue | 4.38 | |||||
| EV-to-FCF | -4.16 | |||||
| Price-to-GF-Value | 0.04 | |||||
| Price-to-Net-Current-Asset-Value | 3.05 | |||||
| Price-to-Net-Cash | 4.25 | |||||
| Earnings Yield (Greenblatt) % | -33.13 | |||||
| FCF Yield % | -14.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cytogen Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 10,910.643 | ||
| EPS (TTM) (â‚©) | -758 | ||
| Beta | 0.09 | ||
| 3-Year Sharpe Ratio | -1.45 | ||
| 3-Year Sortino Ratio | -1.46 | ||
| Volatility % | 48.11 | ||
| 14-Day RSI | 29.74 | ||
| 14-Day ATR (â‚©) | 238.379683 | ||
| 20-Day SMA (â‚©) | 3674.5 | ||
| 12-1 Month Momentum % | -66.71 | ||
| 52-Week Range (â‚©) | 2920 - 13800 | ||
| Shares Outstanding (Mil) | 23.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cytogen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cytogen Inc Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cytogen Inc Frequently Asked Questions
What is Cytogen Inc(XKRX:217330)'s stock price today?
The current price of XKRX:217330 is â‚©3200.00. The 52 week high of XKRX:217330 is â‚©13800.00 and 52 week low is â‚©2920.00.
When is next earnings date of Cytogen Inc(XKRX:217330)?
The next earnings date of Cytogen Inc(XKRX:217330) is .
Does Cytogen Inc(XKRX:217330) pay dividends? If so, how much?
Cytogen Inc(XKRX:217330) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers